scholarly article | Q13442814 |
P2093 | author name string | R. Shah | |
H. Bilal | |||
S. Mahmood | |||
B. Rajashanker | |||
P2860 | cites work | Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients | Q34003208 |
Stereotactic body radiation therapy for inoperable early stage lung cancer | Q34010065 | ||
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer | Q34575077 | ||
Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer | Q37527522 | ||
Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis | Q37592621 | ||
Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation | Q37661974 | ||
Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). | Q47625733 | ||
Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer | Q48345077 | ||
Towards evidence-based medicine in cardiothoracic surgery: best BETS. | Q50892939 | ||
Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. | Q53461549 | ||
Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. | Q53527569 | ||
Stage I nonsmall cell lung cancer in patients aged ≥75 years | Q59587510 | ||
Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer | Q59587541 | ||
Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors | Q80100945 | ||
Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study | Q80587769 | ||
Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates | Q81538048 | ||
Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study | Q83405180 | ||
Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies? | Q84599567 | ||
Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center's experiences | Q84975053 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adaptive radiation therapy | Q180507 |
P304 | page(s) | 258-65 | |
P577 | publication date | 2012-08-01 | |
P1433 | published in | Interactive cardio and thoracic surgery | Q26842415 |
P1476 | title | Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer? | |
P478 | volume | 15 |
Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
Q35663494 | Chinese expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors |
Q38914996 | Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis. |
Q57175083 | Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham's (UK) Experience |
Q26828987 | Expert consensus for thermal ablation of primary and metastatic lung tumors |
Q26799842 | Expert consensus on image-guided radiofrequency ablation of pulmonary tumors-2015 edition |
Q26799881 | Expert consensus on image-guided radiofrequency ablation of pulmonary tumors-2015 edition |
Q35681002 | Expert consensus on image-guided radiofrequency ablation of pulmonary tumors-2015 edition. |
Q57166289 | Expert consensus on image-guided radiofrequency ablation of pulmonary tumors: 2018 edition |
Q47759598 | Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial |
Q38555895 | Novel teatment options in early-stage non-small-cell lung cancer |
Q47110081 | Preliminary comparison of the registration effect of 4D-CBCT and 3D-CBCT in image-guided radiotherapy of Stage IA non-small-cell lung cancer |
Q26851601 | Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients |
Q34404209 | Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification |
Q36743276 | Radiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to know |
Q26747020 | Recent Advances in Bronchoscopic Treatment of Peripheral Lung Cancers |
Q57020608 | Stereotactic Body Radiation Therapy (SBRT) Using CyberKnife in Oligometastatic Cancer Patients; Retrospective Evaluation, Single Institution Experience |
Q59049588 | Stereotactic Hypofractionated Irradiation for Metastatic, Inoperable, and Recurrent Malignancies: A Modern Necessity, rather than a Luxury |
Q38104411 | The electromagnetic spectrum: current and future applications in oncology |
Q38962875 | Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what? |
Q54966227 | Understanding the possibility of image-guided thermal ablation for pulmonary malignancies. |
Q52662210 | [Expert Consensus for Image-guided Radiofrequency Ablation of Pulmonary Tumors (2018 Version)]. |
Q55499005 | [Expert Consensus for Image-guided Radiofrequency Ablation of Pulmonary Tumors]. |
Search more.